C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular DiseaseP.M. Burger, Mariëlle H. Emmelot‐Vonk, Pim A. de Jong et al.|Journal of the American College of Cardiology|2023Cited by 134
C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease LocationsP.M. Burger, Frank L.J. Visseren, Aruna D. Pradhan et al.|The American Journal of Cardiology|2023Cited by 66
Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trialsP.M. Burger, Frank L.J. Visseren, Jannick A N Dorresteijn et al.|Atherosclerosis|2024Cited by 36
Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular diseaseP.M. Burger, Frank L.J. Visseren, Stefan Koudstaal et al.|International Journal of Cardiology|2023Cited by 23
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery diseaseP.M. Burger, Jeroen Schaap, Jannick A N Dorresteijn et al.|European Journal of Preventive Cardiology|2023Cited by 16